Evidence map›Paper›PMID 30571435›Full record

ReviewStroke2018

New Directions in Treatments Targeting Stroke Recovery.

David J Lin, Seth P Finklestein, Steven C Cramer

Abstract readReview
In one paragraph

Review in Stroke, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David J LinFrom the Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital, Boston (D.J.L.).
Seth P FinklesteinStroke Service, Department of Neurology, Massachusetts General Hospital, Boston (S.P.F.).
Steven C CramerDepartment of Neurology, University of California, Irvine (S.C.C.).

Funding

Neuroscience Resident Research ProgramR25NS065743 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CASH, SYDNEY S, WILLIAMS, ZIV · 2009 to 2023
$11.8M
Small Molecule Treatments to Enhance Neurological Recovery After StrokeR44NS095381 · NINDS · STEMETIX, INC. · PI FINKLESTEIN, SETH P · 2018 to 2018
$1.4M
Brain plasticity and rehabilitation after strokeK24HD074722 · NICHD · UNIVERSITY OF CALIFORNIA-IRVINE · PI CRAMER, STEVEN C. · 2013 to 2017
$588k
NICHD NIH HHS K24 HD074722NINDS NIH HHS R25 NS065743NINDS NIH HHS R44 NS095381
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Recovery of FunctionBrain-Computer InterfacesCarbidopaCell- and Tissue-Based TherapyChorionic GonadotropinDopamine AgonistsDrug CombinationsEpoetin AlfaHumansLevodopaOccupational TherapyPhysical Therapy ModalitiesRoboticsSelective Serotonin Reuptake InhibitorsSpeech TherapyStrokeCarbidopacarbidopa, levodopa drug combinationChorionic GonadotropinDopamine AgonistsDrug CombinationsEpoetin AlfaLevodopaSelective Serotonin Reuptake Inhibitorsbrainclinical trialsrehabilitationstroketherapeutics

Identifiers

PMID30571435
PMCPMC6309806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.